We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks and months ahead. Among those we expect to raise the dividend is Pfizer Inc.…
Gartner has released a more calm outlook for semiconductor revenue and PCs in 2012. The report is citing broad uncertainty for the market and the uncertainty of the Euro Zone, as well as Thai…
Up until today, U.S. investors could only invest in (or short sell) the ADRs of National Bank of Greece S.A. (NYSE: NBG), Coca-Cola Hellenic Bottling Company S.A. (NYSE: CCH), or a handful of shipping…
VIVUS, Inc. (NASDAQ: VVUS) is trading higher on news that the SEQUEL study results were published in The American Journal of Clinical Nutrition. The SEQUEL study evaluated the long-term efficacy and safety of Qnexa in…
MEMC Electronic Materials, Inc. (NYSE: WFR) is joining with more pain for its solar (and semiconductor) materials peers. Shares are getting hit this morning on news that it is cutting its global workforce, cutting its…
We already saw the rate cut from the European Central Bank this Thursday morning. Now it is time for the U.S. Labor Department’s weekly announcement on jobless claims. The report put the last week’s…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Thursday morning. Brightpoint Inc. (NASDAQ: CELL) Reiterate as Buy with a $14 price target objective…
As expected, the European Central Bank has followed through with some of the market expectations of a rate cut. Unfortunately, not all rate cuts are created equally. Thursday’s decision from the central bank was a cut…
THQ Inc. (NASDAQ: THQI) has updated its quarterly guidance, and not for the better. The company is issuing a revenue warning which is said to be “primarily due to weaker-than-expected initial sales of its…
Jamie Dimon of J.P. Morgan Chase & Co. (NYSE: JPM) is well-known for being outspoken. At a Goldman Sachs financial conference today, Mr. Dimon spoke out with his usual wording which some believe makes…
You have been reading reports over and over about yet more good news on the retail front as far as consumer spending is concerned. A new Federal Reserve report on consumer credit in the…
With many Master Limited Partnerships (MLPs) trading at or even above some of their expected target prices, we wanted to take a year-end look into the sector to see where there is opportunity versus…
GlassHouse Technologies was supposed to be an initial public offering that the public was looking forward to. After all, it has cloud, virtualization, security and data center services in its description. The company has…
J. C. Penney Company, Inc. (NYSE: JCP) is a company which many investors and outsiders expect to be in a transformation. The first such addition under new management is a stake and investment in Martha…
The Mosaic Co (NYSE: MOS) was given a very positive note from Gabelli & Co. this morning, with an exception. The firm noted, “With corn prices at $5.97 per bushel and the USDA forecasting…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Allstate Corporation (NYSE: ALL) Started as Outperform at Credit Suisse. Amazon.com Inc. (NASDAQ:…
Expedia Inc. (NASDAQ: EXPE) is going to see its shares trade on a WHEN ISSUED basis for it and for its TripAdvisor unit, which shareholders approved the spin-off for on Tuesday afternoon. The details…
Yet another round of insider selling is coming down the pipe. This time it is from clothing and apparel retailer Express, Inc. (NYSE: EXPR). The company announced that insiders and shareholders have filed their…
Spirit Airlines, Inc. (NASDAQ: SAVE) has performed well since its early-summer IPO as a low-cost discount carrier in the United States, the Caribbean, and Latin America. Today is bringing some weakness after the company filed…
AuthorDendreon Corporation (NASDAQ: DNDN) is supposed to be the king of prostate cancer with its PROVENGE treatment. Unfortunately, PROVENGE sales ran slower than expected after the FDA took forever to approve it and after…